Singapore markets open in 1 hour 26 minutes

hVIVO plc (CRO.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.2180+0.0100 (+4.81%)
At close: 08:09AM CET
Full screen
Previous close0.2080
Bid0.2220 x N/A
Ask0.2580 x N/A
Day's range0.2180 - 0.2180
52-week range0.0950 - 0.2440
Avg. volume0
Market cap153.981M
Beta (5Y monthly)1.02
PE ratio (TTM)
EPS (TTM)0.0000
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date04 May 2023
1y target estN/A
  • Reuters

    hVIVO raises 2023 revenue view on demand for respiratory therapy testings

    Drugmakers are in a race to develop vaccines and drugs to treat respiratory diseases caused by respiratory syncytial virus and COVID-19, resulting in increased demand for clinical testing of the products. The contract research organisation now expects its annual revenue to be 55 million pounds ($68.8 million), compared with 53 million pounds it previously expected.